Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.

ABSTRACT:

Background

Existing clinical trial data do not address whether all angiotensin-converting-enzyme (ACE) inhibitors are similarly beneficial in improving survival and reducing the rate of readmission among patients with congestive heart failure. We sought to answer this question using administrative databases from Canada's 3 most populous provinces.

Methods

Using linked hospital discharge and prescription claims databases in Quebec, Ontario and British Columbia, we identified all patients 65 years or older who were admitted to hospital because of congestive heart failure between Jan. 1, 1998, and Mar. 31, 2002, and who had not been admitted for the same reason in the 3 years preceding the study period. We analyzed the association between the type of ACE inhibitor prescribed wi

SUBMITTER: Pilote L 

PROVIDER: S-EPMC2335176 | biostudies-literature | 2008 May

REPOSITORIES: biostudies-literature